← The Wire
GRALNasdaq
GRAIL, Inc.
Services-Medical Laboratories · DE · CIK 1699031
GRAIL, Inc. detects many cancers early with a single blood test to improve outcomes
red 8-K · 90d🔥 High media attention
$2.57B
Market cap
$68.39
Last close
+3.8%
1D
+10.1%
5D
483K
Volume
Price · last 39 sessions+22.9%
May 4L $54.40 · H $73.92Jun 29
45
Total filings
Jun 22, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 22, 20268-KExecutive Change · Company UpdateJun 1, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 5, 2026DEFA14ADEFA14AApr 28, 2026DEF 14ADEF 14AApr 28, 202610-K10-KMar 12, 20268-KResults of Operations · Company UpdateFeb 19, 20268-KResults of OperationsJan 12, 20268-KCompany UpdateNov 14, 2025424B5424B5Nov 14, 202510-Q10-QNov 13, 20258-KResults of OperationsNov 12, 20258-KMaterial Agreement · Equity IssuanceOct 20, 20258-KMaterial Agreement · Results of OperationsOct 16, 20258-KMaterial Agreement · New Debt / ObligationSep 18, 202510-Q10-QAug 13, 20258-KResults of OperationsAug 12, 20258-KShareholder VoteMay 30, 20258-KExecutive ChangeMay 16, 202510-Q10-QMay 14, 20258-KResults of OperationsMay 13, 2025DEF 14ADEF 14AApr 15, 2025DEFA14ADEFA14AApr 15, 2025DEF 14ADEF 14AApr 15, 202510-K10-KMar 5, 20258-KResults of OperationsFeb 20, 20258-KResults of OperationsJan 15, 2025SC 13GSC 13GNov 14, 202410-Q10-QNov 13, 2024SC 13GPRIMECAP MANAGEMENT CO/CA/Nov 12, 20248-KResults of OperationsNov 12, 20248-KExecutive Change · Reg FD DisclosureOct 22, 2024SC 13GSC 13GAug 30, 202410-Q10-QAug 13, 20248-KResults of OperationsAug 13, 20248-KReg FD DisclosureAug 6, 20248-K/AExecutive ChangeJul 2, 20248-KMaterial ImpairmentJun 27, 20248-KChange of Control · Executive ChangeJun 24, 20248-KExecutive ChangeJun 12, 20248-K/ACompany UpdateJun 6, 20248-KCompany UpdateJun 3, 2024S-1/AS-1/ASep 17, 2020S-1S-1Sep 9, 2020
Insider Activity
In the 90 days to Mar 9, 2026: 3 sold $4.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 9, 2026 | Ragusa Robert PChief Executive Officer | Sell | 7,203 | $47.93 | $345K |
| Mar 9, 2026 | Ofman Joshua J.President | Sell | 2,836 | $47.93 | $136K |
| Mar 9, 2026 | Freidin AaronChief Financial Officer | Sell | 2,407 | $47.93 | $115K |
| Mar 9, 2026 | Ragusa Robert PChief Executive Officer | Sell | 258 | $46.73 | $12K |
| Mar 9, 2026 | Ofman Joshua J.President | Sell | 101 | $46.74 | $5K |
| Mar 9, 2026 | Freidin AaronChief Financial Officer | Sell | 85 | $46.74 | $4K |
| Mar 5, 2026 | Ragusa Robert PChief Executive Officer | Sell | 980 | $53.01 | $52K |
| Mar 5, 2026 | Ofman Joshua J.President | Sell | 690 | $53.01 | $37K |
| Mar 5, 2026 | Freidin AaronChief Financial Officer | Sell | 655 | $53.01 | $35K |
| Mar 2, 2026 | Ragusa Robert PChief Executive Officer | Sell | 35,787 | $50.09 | $1.8M |
| Mar 2, 2026 | Ofman Joshua J.President | Sell | 16,223 | $50.09 | $813K |
| Mar 2, 2026 | Freidin AaronChief Financial Officer | Sell | 9,135 | $50.09 | $458K |
| Mar 2, 2026 | Ragusa Robert PChief Executive Officer | Sell | 1,717 | $51.84 | $89K |
| Mar 2, 2026 | Ofman Joshua J.President | Sell | 779 | $51.75 | $40K |
| Mar 2, 2026 | Freidin AaronChief Financial Officer | Sell | 438 | $51.86 | $23K |
| Dec 3, 2025 | Freidin AaronChief Financial Officer | Sell | 25,000 | $99.15 | $2.5M |
| Dec 3, 2025 | Ragusa Robert PChief Executive Officer | Sell | 15,356 | $95.28 | $1.5M |
| Dec 3, 2025 | Ragusa Robert PChief Executive Officer | Sell | 14,807 | $94.43 | $1.4M |
| Dec 3, 2025 | Ofman Joshua J.President | Sell | 13,000 | $100.00 | $1.3M |
| Dec 3, 2025 | Ragusa Robert PChief Executive Officer | Sell | 8,233 | $96.22 | $792K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
🔥 High media attentionCoverage (30d): 6 reputable articles · skews ▼ negative.
Financial TimesGRAIL, Inc. (GRAL) Faces Securities Class Action Amid NHS-Galleri Trial Failure, $2.2B Market Cap Wipeout -- HBSS4d agoFinancial TimesGRAL INVESTOR NOTICE: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company Announcement - FT.com15d agoFortuneSpaceX’s record IPO has Wall Street torn between a Musk ‘holy grail’ and a $135-per-share leap of faith19d agoMorningstarLevi & Korsinsky Reminds Grail, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 4, 2026 - GRAL19d agoMorningstarGRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit22d agoInvestor's Business DailyGrail Plummets On Mixed Results For Cancer-Screening Blood Test29d ago
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance